The weekly litigation news digest is live. Subscribe now

IP Verse

Identifying Patient Response To S1P Receptor Modulator Administration

Patent No. EP3647783 (titled "Identifying Patient Response To S1P Receptor Modulator Administration") was filed by Novartis on Apr 19, 2013. The application was issued on Dec 21, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KRAUS & LEDERER PARTGMBBSep 21, 2023KRAUS & LEDERER PARTGMBB
SYNTHONSep 21, 2023HAMM & WITTKOPP
VENNER SHIPLEYSep 21, 2023RUSSELL
KILBURN & STRODESep 20, 2023LEONARD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3647783

NOVARTIS
Application Number
EP19204477A
Filing Date
Apr 19, 2013
Status
Granted And Under Opposition
Nov 18, 2022
Publication Date
Dec 21, 2022
External Links
Slate, Register, Google Patents